Carrier Advisory Committee Letter

Please note: When billing ALOXI using J2469, the billing unit is 25 mcg.
ALOXI should be billed at 10 units for a 0.25 mg dose.

Click here to download a template for the Carrier Advisory Committee Letter.

*ALOXI is used in adults to help prevent the nausea and vomiting that can happen on the day of treatment with certain chemotherapies or occur days later following certain chemotherapies moderately likely to cause nausea and vomiting.

Tell your healthcare professional if you are taking other medications or if you have or develop severe heartbeat changes. The most common side effects of ALOXI are headache and constipation. ALOXI is available by prescription only. For more information, please see the Patient Product Information for ALOXI.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.